Pancras C.W. Hogendoorn#
| Membership Number: | 4916 |
| Membership type: | ORDINARY |
| Section: | CLINICAL & VETERINARY SCIENCE |
| Elected: | 2019 |
| Main Country of Residence: | THE NETHERLANDS |
| Homepage(s): | https://www.universiteitleiden.nl/en/staffmembers/pancras-hogendoorn |
| ORCID: | 0000-0002-1513-8104 |
Present and Previous Positions
- 2016 - present: Chair of the Biomedical group of the League of European Research Universities (LERU)
- 2012 - present: Vice-Chair of the Board of Directors and Dean of Leiden University Medical Center (LUMC), The Netherlands
- 2010 - present: Visiting Professor in Sarcoma Pathology at the University of Oxford, UK, associated to Lincoln College
- 2017 - present: Visiting Professor of Pathology at the Free University of Brussels, Belgium
- 1998 - present Professor of Pathology, Leiden University/Leiden University Medical Center
- 1994 - present Reference-pathologist for the European Osteosarcoma Intergroup and EuroEwing consortium
- 2012 - 2019: Chairman of the Executive Committee on Research & Education of the Netherlands Federation of University Medical Centres (NFU)
- 2008 - 2019: Chairman Working group on Bone and Soft tissue tumours European Society of Pathology
- 2002 - 2012: Chairman of the Pathology Subcommittee Euro-Ewing Consortium
- 2000 - 2019: Chairman Pathology Subcommittee European Osteosarcoma Intergroup/reference pathologist
Fields of Scholarship
- Cloned causative mutations in the IDH1 and IDH2 genes in enchondroma, central chondrosarcoma and dedifferentiated chondrosarcoma
- Osteoblastoma (del chrom 22)
- Angiomatoid fibrous histiocytoma (EWSR1-CREB1/ATF1)
- Molecular pathogenesis and genetics of bone and soft tissue sarcomas
- Adult spindle cell rhabdomyosarcoma (MYOD1)
- Elucidated the tumour suppressor function of EXT1/2 in osteochondroma and peripheral chondrosarcoma
- Discovered causative somatic genetic background in Chondromyxoid fibroma (GRM1)
- Development and validation of (dynamic) contrast-enhanced magnetic resonance imaging (MRI) of bone and soft tissue tumours
- Osteosarcoma (SMAD and GLI-mediated pathways, del P16 and stem cell tumourigenesis)
- Cloned unique translocation inEwing-like sarcoma (NFATC2)
Honours and Awards
- 2019 Doctor Honoris Causa Semmelweis University, Budapest, Hungary
- 2019 Member of Academia Europaea
- 2018 Vitaal Award by Athena’s Angels for his long-term support for the position of female researchers at LUMC
- 2018 Eurolife Distinguished Lecture ‘Understanding Cartilaginous Tumours’, Eurolife Symposium, Semmelweis University, Hungary
- 2017 - present Visiting Professor of Pathology at the Free University of Brussels, Belgium
- 2015 Jeremy Jass Prize for research excellence in pathology
- 2013 Nina Axelrad award of the Connective Tissue Oncology Society (CTOS)
- 2012 - present Honorary Membership of the Belgian Society of Pathology
- 2011 Jeremy Jass Prize for research excellence in pathology
- 2011 Campanacci lecturer at the European Musculoskeletal Oncology Society
- 2011 - 2018 EUROSARC: European Clinical trials in Rare Sarcomas within an integrated translational trial network; EU-FP7 collaborative project
- 2010 - present Visiting Professor in Sarcoma Pathology at the University of Oxford, UK, associated to Lincoln College
- 2009 ENCCA: EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS; focussing for LUMC on bone cancer; EU-FP7; €169.384 (WP leader)
- 2008 EMSOS lecturer at te European Musculoskelatal Oncology Society
- 2008 European Oswald Vander Vekenprijs (in recognition of an original contribution to knowledge about the tumours of the locomotor system, their etiology, prevention, diagnosis and/or treatment)
- 2006 - 2012 Network Chairman EuroBonet, a European Network to promote research into uncommon cancers in adults and children
- 2006 - 2008 Visiting Professor at the University of Bologna; Rizzoli Orthopaedic Institute, Bologna, Italy
- 1998 Corrine Farrel Award of the International Skeletal Society
- 1994 Corrine Farrel Award of the International Skeletal Society
